16:01 Dec 27
Jenburkt Pharmaceuticals Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Jenburkt Pharmaceuticals Ltd.
70/100 High Financial Strength
Quality47/100 Mid Valuation
Valuation60/100 Technically Neutral
TechnicalSWOT
Strength
8
Weakness
0
Opportunity
0
Threat
0
529.60
Market Cap (Cr)
-
PE Ratio
3.36
Price to Book Ratio
45.01
RSI
0.00 %
Net Profit Margin
SWOT
Download Our App On:
